EGFR and cancer: Accumulating evidence has demonstrated that down-regulation of miR-145 significantly promotes cancer progression: conversely, up-regulation of miR-145 significantly inhibits cancer progression by targeting cellular pathways, such as Wnt/β-catenin, PI3K/AKT and EGFR [32,33].